Probiotics and Covid-19.
Int J Food Sci Nutr
; 72(3): 293-299, 2021 May.
Article
in English
| MEDLINE | ID: covidwho-1169469
ABSTRACT
Coronavirus disease 2019 (COVID-19) has become pandemic very rapidly at the beginning of 2020. In the rush to possible therapeutic options, probiotics administration has been proposed mainly based on indirect observation. Some evidence of COVID-19 effects on intestinal microbiota dysbiosis has been shown and probiotics have been considered for their efficacy in the management of respiratory tract viral infections. These observations could be reinforced by the more and more evident existence of a lung-gut axis, suggesting the modulation of gut microbiota among the approaches to the COVID-19 prevention and treatment. As different possible roles of probiotics in this extremely severe illness have been contemplated, the aim of this work is to collect all the currently available information related to this topic, providing a starting point for future studies focussing on it.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Probiotics
/
Dysbiosis
/
Gastrointestinal Microbiome
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Int J Food Sci Nutr
Journal subject:
Nutritional Sciences
Year:
2021
Document Type:
Article
Affiliation country:
09637486.2020.1807475
Similar
MEDLINE
...
LILACS
LIS